Popular GLP-1 drugs prescribed for Type 2 diabetes and weight loss could also slow aging, according to recent animal testing and drugmakers' preliminary analysis of human data.
GLP-1 drugs, used in the treatment of diabetes and obesity, can do more than help to lose weight. New studies suggest that drugs such as semaglutide and tirzepatide may slow the biological aging of organs and tissues. The results are promising, but scientists warn that it is still early to conclude that these drugs prolong human life.